BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19474743)

  • 21. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of gastro-oesophageal reflux disease in primary care: a European observational study.
    Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Tafalla M
    Curr Med Res Opin; 2009 Nov; 25(11):2777-84. PubMed ID: 19785512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Symptom profile in gastroesophageal reflux disease in untreated patients and those with persistent symptoms despite treatment].
    Ponce J; Mearin F; Ponce M; Balboa A; Zapardiel J
    Gastroenterol Hepatol; 2010 Apr; 33(4):271-9. PubMed ID: 20133018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions and practices on the management of gastro-oesophageal reflux disease: results of a national survey comparing primary care physicians and gastroenterologists.
    Bretagne JF; Honnorat C; Richard-Molard B; Soufflet C; Barthélemy P
    Aliment Pharmacol Ther; 2007 Apr; 25(7):823-33. PubMed ID: 17373921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance treatment for GERD: residual symptoms are associated with psychological distress.
    van der Velden AW; de Wit NJ; Quartero AO; Grobbee DE; Numans ME
    Digestion; 2008; 77(3-4):207-13. PubMed ID: 18617743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
    Bretagne JF; Honnorat C; Richard-Molard B; Caekaert A; Barthélemy P
    Aliment Pharmacol Ther; 2006 Mar; 23(5):607-16. PubMed ID: 16480400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study.
    Ezzat WF; Fawaz SA; Fathey H; El Demerdash A
    J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):350-6. PubMed ID: 21777555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom evaluation in gastroesophageal reflux disease.
    Modlin IM; Moss SF
    J Clin Gastroenterol; 2008; 42(5):558-63. PubMed ID: 18364584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GERD management. Strategies recommended for primary care practice.
    Kuritzky L; Rodney WM
    Postgrad Med; 2001 Oct; Spec No():11-8. PubMed ID: 11868426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heartburn in primary care: problems below the surface.
    Holtmann G; Maldonado-Lopez E; Haag S
    J Gastroenterol; 2004 Nov; 39(11):1027-34. PubMed ID: 15580394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux disease in pregnancy.
    Ali RA; Egan LJ
    Best Pract Res Clin Gastroenterol; 2007; 21(5):793-806. PubMed ID: 17889808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.